US drug sales growth continues slowdown in 2008

(AP) -- Sales growth of prescription drugs in the U.S. slowed for the second straight year, with the economic downturn playing a key role, according to IMS Health Inc.

Market research firm IMS cites lower demand for less-expensive generic drugs, lagging new product , and reduced consumer demand. Sales rose just 1.3 percent to $291 billion in 2008. That about matches IMS' prior outlook of 1 percent to 2 percent growth.

In 2007, U.S. sales rose 3.8 percent to $286.5 billion, while they gained 8 percent in 2006.

Anti-psychotic drugs were the lead sales drivers, followed by and treatments for heartburn and related conditions.

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


Explore further

Global semiconductor sales up 1.7 percent

Citation: US drug sales growth continues slowdown in 2008 (2009, March 19) retrieved 25 February 2020 from https://medicalxpress.com/news/2009-03-drug-sales-growth-slowdown.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments